Real-world safety analysis of deutetrabenazine post-marketing: a disproportionality study leveraging the FDA Adverse Event Reporting System (FAERS) database.

BMC Pharmacol Toxicol · 2025 · PMC11846250 · PMID 39985106

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

This β value indicated a decreasing trend in AE occurrence over time, suggesting a pattern often linked with early adverse reactions.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.